310 Efficacy and safety of abrocitinib in biologic-exposed versus biologic-naïve patients with moderate-to-severe atopic dermatitis
- Resource Type
- Source
- Journal of Investigative Dermatology. 142:S53
- Subject
Cell Biology Dermatology Molecular Biology Biochemistry - Language
- ISSN
- 0022-202X